Farther Finance Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
6,544
+1,496
| +30% | +$607K | 0.05% | 296 |
|
|
2025
Q1 | $2.44M | Buy |
5,048
+1,100
| +28% | +$531K | 0.06% | 258 |
|
|
2024
Q4 | $2.05M | Buy |
3,948
+124
| +3% | +$64.5K | 0.07% | 220 |
|
|
2024
Q3 | $2.37M | Buy |
3,824
+539
| +16% | +$333K | 0.09% | 184 |
|
|
2024
Q2 | $1.78M | Buy |
3,285
+1,051
| +47% | +$569K | 0.09% | 185 |
|
|
2024
Q1 | $1.29M | Buy |
2,234
+509
| +30% | +$294K | 0.08% | 210 |
|
|
2023
Q4 | $916K | Buy |
1,725
+530
| +44% | +$281K | 0.07% | 249 |
|
|
2023
Q3 | $605K | Buy |
1,195
+39
| +3% | +$19.7K | 0.1% | 179 |
|
|
2023
Q2 | $603K | Buy |
1,156
+254
| +28% | +$133K | 0.13% | 142 |
|
|
2023
Q1 | $520K | Buy |
902
+632
| +234% | +$364K | 0.15% | 126 |
|
|
2022
Q4 | $149K | Buy |
+270
| New | +$149K | 0.06% | 261 |
|